Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayashree Karar

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Neuroscience Research|January 10, 2008
YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatmentIshwar Dutt Vats, Karamjit Singh Dolt, Krishan Kumar, et al.
Journal of Cardiovascular Pharmacology|December 13, 2012
Sulfur-containing angiotensin-converting enzyme inhibitor 3-thienylalanine-ornithyl-proline activates endothelial function and expression of genes involved in Renin-Angiotensin systemSnehlata Chaudhary, Mahesh Kumar Seth, Ishwar Dutt Vats, et al.
Cancer Research|December 30, 2017
Familial and Somatic <i>BAP1</i> Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent DomainsHongzhuang Peng, Jeremy Prokop, Jayashree Karar, et al.
Plos Pathogens|November 21, 2014
Structure and specificity of the bacterial cysteine methyltransferase effector NleE suggests a novel substrate in human DNA repair pathwayQing Yao, Li Zhang, Xiaobo Wan, et al.
Cancer Research|January 27, 2011
In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissectionDiane Marotta, Jayashree Karar, W Timothy Jenkins, et al.
Cancer Research|June 15, 2014
Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesotheliomaJinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, et al.
Molecular Therapy. Methods & Clinical Development|January 29, 2024
Long-term stability of clinical-grade lentiviral vectors for cell therapyJulie K Jadlowsky, Rachel Leskowitz, Stephen McKenna, et al.
Cancer Research|March 5, 2014
LIMD2 is a small LIM-only protein overexpressed in metastatic lesions that regulates cell motility and tumor progression by directly binding to and activating the integrin-linked kinaseHongzhuang Peng, Mehdi Talebzadeh-Farrooji, Michael J Osborne, et al.
Nature Biomedical Engineering|March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancerGregory M Chen, Ankita Jain, David T Gering, et al.
Nature Medicine|January 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapiesJulie K Jadlowsky, Elizabeth O Hexner, Amy Marshall, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Neuroscience Research|January 10, 2008
YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatmentIshwar Dutt Vats, Karamjit Singh Dolt, Krishan Kumar, et al.
Journal of Cardiovascular Pharmacology|December 13, 2012
Sulfur-containing angiotensin-converting enzyme inhibitor 3-thienylalanine-ornithyl-proline activates endothelial function and expression of genes involved in Renin-Angiotensin systemSnehlata Chaudhary, Mahesh Kumar Seth, Ishwar Dutt Vats, et al.
Cancer Research|December 30, 2017
Familial and Somatic <i>BAP1</i> Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent DomainsHongzhuang Peng, Jeremy Prokop, Jayashree Karar, et al.
Plos Pathogens|November 21, 2014
Structure and specificity of the bacterial cysteine methyltransferase effector NleE suggests a novel substrate in human DNA repair pathwayQing Yao, Li Zhang, Xiaobo Wan, et al.
Cancer Research|January 27, 2011
In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissectionDiane Marotta, Jayashree Karar, W Timothy Jenkins, et al.
Cancer Research|June 15, 2014
Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesotheliomaJinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, et al.
Molecular Therapy. Methods & Clinical Development|January 29, 2024
Long-term stability of clinical-grade lentiviral vectors for cell therapyJulie K Jadlowsky, Rachel Leskowitz, Stephen McKenna, et al.
Cancer Research|March 5, 2014
LIMD2 is a small LIM-only protein overexpressed in metastatic lesions that regulates cell motility and tumor progression by directly binding to and activating the integrin-linked kinaseHongzhuang Peng, Mehdi Talebzadeh-Farrooji, Michael J Osborne, et al.
Nature Biomedical Engineering|March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancerGregory M Chen, Ankita Jain, David T Gering, et al.
Nature Medicine|January 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapiesJulie K Jadlowsky, Elizabeth O Hexner, Amy Marshall, et al.
Pageof 2